nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
AI-CAD for tuberculosis and other global high-burden diseases
|
Arentz, Matthew |
|
|
5 |
3 |
p. e115 |
artikel |
2 |
ChatGPT: friend or foe?
|
The Lancet Digital Health, |
|
|
5 |
3 |
p. e102 |
artikel |
3 |
ChatGPT: the future of discharge summaries?
|
Patel, Sajan B |
|
|
5 |
3 |
p. e107-e108 |
artikel |
4 |
Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with hypertension: a systematic review and meta-analysis of randomised controlled trials
|
Siopis, George |
|
|
5 |
3 |
p. e144-e159 |
artikel |
5 |
Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
|
Moschonis, George |
|
|
5 |
3 |
p. e125-e143 |
artikel |
6 |
Embedding patient-reported outcomes at the heart of artificial intelligence health-care technologies
|
Cruz Rivera, Samantha |
|
|
5 |
3 |
p. e168-e173 |
artikel |
7 |
Generating scholarly content with ChatGPT: ethical challenges for medical publishing
|
Liebrenz, Michael |
|
|
5 |
3 |
p. e105-e106 |
artikel |
8 |
Home telemonitoring versus hospital care in complicated pregnancies in the Netherlands: a randomised, controlled non-inferiority trial (HoTeL)
|
Bekker, Mireille N |
|
|
5 |
3 |
p. e116-e124 |
artikel |
9 |
Safe care from home for complicated pregnancies?
|
Tucker, Katherine L |
|
|
5 |
3 |
p. e103-e104 |
artikel |
10 |
Thank you to The Lancet Digital Health's statistical and peer reviewers in 2022
|
The Lancet Digital Health Editors, |
|
|
5 |
3 |
p. e112-e114 |
artikel |
11 |
The role of patient-reported outcome measures in trials of artificial intelligence health technologies: a systematic evaluation of ClinicalTrials.gov records (1997–2022)
|
Pearce, Finlay J |
|
|
5 |
3 |
p. e160-e167 |
artikel |
12 |
US COVID-19 clinical trial leadership gender disparities
|
Sehgal, Neil K R |
|
|
5 |
3 |
p. e109-e111 |
artikel |